3-D Structure of Serum Paraoxonase 1 Sheds Light on Its Activity, Stability, Solubility and Crystallizability
Serum paraoxonases (PONs) exhibit a wide range of physiologically important hydrolytic activities, including drug metabolism and detoxification of nerve gases. PON1 and PON3 reside on high-density lipoprotein (HDL) (the "good cholesterol"), and are involved in the alleviation of atherosclerosis. Members of the PON family have been identified not only in mammals and other vertebrates, but also in invertebrates. We earlier described the first crystal structure of a PON family member, a directly-evolved variant of PON1, at 2.2 Å resolution. PON1 is a 6-bladed beta-propeller with a unique active-site lid which is also involved in binding to HDL. The 3-D structure, taken together with directed evolution studies, permitted analysis of mutations which enhanced the stability, solubility and crystallizability of this PON1 variant. The structure permits a detailed description of PON1's active site and suggests possible mechanisms for its catalytic activity on certain substrates.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Draganov DI La Du BN. Pharmacogenetics of paraoxonases: a brief review. Naunyn-Schmiedeberg's Arch Pharmacol 2004;369:78-88.
Lusis AJ. Atherosclerosis. Nature 2000;407:233-41.
Shih DM Gu L Xia YR Navab M Li WF Hama S Castellani LW Furlong CE Costa LG Fogelman AM Lusis AJ. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998;394:284-7.
Mackness MI Arrol S Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. Fed Eur Biochem Soc Lett 1991;286:152-4.
Reddy ST Wadleigh DJ Grijalva V Ng C Hama S Gangopadhyay A Shih DM Lusis AJ Navab M Fogelman AM. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 2001;21:542-7.
Rodrigo L Mackness B Durrington PN Hernandez A Mackness MI. Hydrolysis of platelet-activating factor by human serum paraoxonase. Biochem J 2001;354:1-7.
Ahmed Z Ravandi A Maguire GF Emili A Draganov D La Du BN Kuksis A Connelly PW. Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor. J Biol Chem 2001;276:24473-81.
Jakubowski H. Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. J Biol Chem 2000;275:3957-62.
Lund-Katz S Liu L Thuahnai ST Phillips MC. High density lipoprotein structure. Front Biosci 2003;8: d1044-54.
Fuhrman B Volkova N Aviram M. Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase. Atherosclerosis 2002;161:307-16.
Rozenberg O Shih DM Aviram M. Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation. Arterioscler Thromb Vasc Biol 2003;23:461-7.
Sorenson RC Bisgaier CL Aviram M Hsu C Billecke S La Du BN. Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity. Arterioscler Thromb Vasc Biol 1999;19:2214-25.
Aharoni A Gaidukov L Yagur S Toker L Silman I Tawfik DS. Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization. Proc Natl Acad Sci USA 2004;101:482-7.
Harel M Aharoni A Gaidukov L Brumshtein B Khersonsky O Meged R Dvir H Ravelli RB McCarthy A Toker L Silman I Sussman JL Tawfik DS. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 2004;11:412-9.
Morales R Berna A Carpentier P Contreras-Martel C Renault F Nicodeme M Chesne-Seck ML Bernier F Dupuy J Schaeffer C Diemer H Van-Dorsselaer A Fontecilla-Camps JC Masson P Rochu D Chabriere E. Discovery and crystallographic structure of human apolipoprotein. Ann Pharm 2000;65:98-107.
Josse D Ebel C Stroebel D Fontaine A Borges F Echalier A Baud D Renault F Le Maire M Chabriere E Masson P. Oligomeric states of the detergent-solubilized human serum paraoxonase (PON1). J Biol Chem 2002;277:33386-97.
Rosenblat M Gaidukov L Khersonsky O Vaya J Oren R Tawfik DS Aviram M. The catalytic His dyad of High Density Lipoprotein-associated serum paraoxonase-I (PON1) is essential for PON1-mediated inhibition of Low Density Lipoprotein oxidation and stimulation of macrophage cholesterol efflux. J Biol Chem 2006;281:7657-66.
Khersonsky O Tawfik DS. The histidine-115 histidine-134 dyad mediates the lactonase activity of mammalian serum paraoxonases. J Biol Chem 2006;281:7649-56.
Kuo CL La Du BN. Comparison of purified human and rabbit serum paraoxonases. Drug Metab Dispos 1995;23:935-44.
Roodveldt C Aharoni A Tawfik DS. Directed evolution of proteins for heterologous expression and stability. Curr Opin Struct Biol 2005;15:50-6.
Sekar K Yu BZ Rogers J Lutton J Liu X Chen X Tsai MD Jain MK Sundaralingam M. Phospholipase A2 engineering. Structural and functional roles of the highly conserved active site residue aspartate-99. Biochemistry 1997;36:3104-14.
Scharff EI Koepke J Fritzsch G Lucke C Ruterjans H. Crystal structure of diisopropylfluorophosphatase from Loligo vulgaris. Structure (Camb) 2001;9:493-502.
Waldo GS. Genetic screens and directed evolution for protein solubility. Curr Opin Chem Biol 2003;7:33-8.
Roodveldt C Tawfik DS. Directed evolution of phosphotriesterase from Pseudomonas diminuta for heterologous expression in Escherichia coli results in stabilization of the metal-free state. Protein Eng Des Sel 2005;18:51-583.